By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Integral Molecular, Inc. 

3701 Market Street, Suite 340

Philadelphia  Pennsylvania  19104  U.S.A.
Phone: 215-966-6018 Fax:



Start Up

Company News
Integral Molecular, Inc. Launches Target Specificity Technology To Improve Safety Of Biotherapeutics 9/22/2016 12:10:38 PM
Integral Molecular, Inc. Announces Breakthrough In Understanding The Functionality Of Gpcrs, The Largest Class Of Drug Targets In Human Disease 8/26/2016 9:01:49 AM
Integral Molecular, Inc. Develops B-Cell Cloning Technology To Discover Rare Antibodies Against Membrane Proteins 5/27/2016 11:16:51 AM
Integral Molecular, Inc. Expands Intellectual Property Landscape With International Patents Protecting Key Lipoparticle Technology 2/11/2016 9:46:24 AM
DNA Immunization Expert Dr. Ross Chambers Joins Integral Molecular, Inc. To Lead Antibody Discovery 12/11/2015 10:58:12 AM
Integral Molecular, Inc. Identifies Key Molecular Interactions Responsible For The Effectiveness Of The ZMapp Anti-Ebola Virus Cocktail 11/13/2015 11:54:14 AM
Integral Molecular, Inc. Awarded $5.5 Million By The NIH To Study Ebola Antibodies To Aid In Vaccine Discovery 10/15/2015 12:35:46 PM
Integral Molecular, Inc. Identifies Potent Inhibitory Antibodies Against Chikungunya Virus 12/11/2014 7:45:56 AM
Integral Molecular, Inc. Awarded $3.5M Contract From NIH To Study Ebola And Hepatitis C Virus Antibody Response 11/14/2014 10:46:31 AM
Integral Molecular, Inc. Announces Patent Allowance For Dengue Research Technology 7/18/2014 10:44:47 AM